Who is sponsoring NCT05360329?

NCT05360329 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05360329?

Interventions in NCT05360329: Transarterial geniculate artery embolization.

What condition does NCT05360329 study?

NCT05360329 studies Knee Osteoarthritis.

Is NCT05360329 still recruiting?

NCT05360329 is currently completed. Last updated 20 December 2024.

Last reviewed 2024-12-20 · How we verify

NCT05360329: GETKO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genicular Artery Embolization as Pain Treatment of Knee Osteoarthritis

Completed NA Last updated 20 December 2024

What this trial tests

NA trial testing Transarterial geniculate artery embolization in Knee Osteoarthritis in 17 participants. Completed in 19 December 2023.

Timeline

20 September 2022

Primary endpoint
19 December 2023

19 December 2023

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	20 September 2022
Primary completion	19 December 2023
Estimated completion	19 December 2023
Sites	1 location across Denmark

Drugs / interventions tested

Transarterial geniculate artery embolization

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

Rigshospitalet, Denmark

Who can join

30 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the safety and efficacy of geniculate artery embolization (GAE) as pain treatment in patients with mild to moderate knee osteoarthritis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Transarterial Embolization of Geniculate Arteries Reduces Pain and Improves Physical Function in Knee Osteoarthritis-A Prospective Cohort Study.
Hindsø L, Hölmich P, Petersen MM, Nielsen MB, et al · · 2024 · cited 5× · PMID 39125502 · DOI 10.3390/diagnostics14151627
Reduction in Synovitis Following Genicular Artery Embolization in Knee Osteoarthritis: A Prospective Ultrasound and MRI Study.
Hindsø L, Hölmich P, Petersen MM, Xu JJ, et al · · 2024 · cited 4× · PMID 39594229 · DOI 10.3390/diagnostics14222564

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05360329 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 20 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05360329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing